Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

GTC begins study of rhATIII in patients with hereditary antithrombin deficiency

Dec. 11, 2002

Superior efficacy and safety demonstrated for GH-9001 versus other anticoagulants in rabbits

Dec. 11, 2002

New factor Xa inhibitors in early development at BMS

Dec. 2, 2002

Morphochem enters research collaboration with AstraZeneca for novel antithrombotics

Nov. 27, 2002

Series of esterase-susceptible anticoagulants covered by ARYx patent

Nov. 25, 2002

New PAR1 antagonists discovered by Eisai scientists

Nov. 25, 2002

Prehospital TNKase treatment of heart attack feasible and faster than in-hospital treatment

Nov. 25, 2002

New antithrombotic compounds under study at Boehringer Ingelheim

Nov. 21, 2002

First safety and pharmacokinetic data of the thrombolytic BB-10153 in humans

Nov. 20, 2002

Effects of DPC-423 in rabbit model suggest clinical utility in preventing arterial thrombosis

Nov. 19, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...